乌鸦传媒

<乌鸦传媒 class="page-title">Clinical Challenges

Bladder Cancer

<乌鸦传媒 class="page-description">

More in Bladder Cancer

Clinical Challenge: Urinary Diversion Methods in Bladder Cancer

Patients should be well informed about pros, cons of the options

Dec 06, 2021
A female physician checks her female patients urostomy
Clinical Challenges: First-Line Immunotherapy Eligibility in Advanced Bladder Cancer

For those who are candidates, data are lacking on how to choose between available options

Nov 22, 2021
Vials of Tecentriq (atezolizumab) and Keytruda (pembrolizumab) over a computer rendering of bladder cancer.

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis